Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
Company Details
- Employees
- 172
- Founded
- -
- Address
- 3115 Merryfield Row,
- PR****@****Bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gossamerbio.com
- Keywords
- Pulmonary hypertension.
- HQ
- San Diego, California
Gossamer Bio Questions
Gossamer Bio's website is gossamerbio.com
Gossamer Bio's LinkedIn profile is https://www.linkedin.com/company/gossamer-bio
Gossamer Bio has
172 employees.
View email and phone details for 172
employees at Gossamer Bio.
Gossamer Bio's industry is
Biotechnology Research
Gossamer Bio's support email address is PR@GossamerBio.com
Gossamer Bio's categories are Biotechnology Research
Gossamer Bio's founding year is 2017
